Inhibition of Polymicrobial Biofilms of Candida albicans - Staphylococcus aureus / Streptococcus mutans by Fucoidan-Gold Nanoparticles.
Nazia TabassumFazlurrahman KhanMin-Gyun KangDu-Min JoKyung-Jin ChoYoung-Mog KimPublished in: Marine drugs (2023)
The polymicrobial proliferation and development of complex biofilm morphologies by bacterial and fungal pathogens in the host are some of the key factors contributing to the failure of antimicrobial treatments. The polymicrobial interaction of Candida albicans and some bacterial species has been extensively studied in both in vitro and in vivo model systems. Alternative strategies for disrupting polymicrobial interaction and biofilm formation are constantly needed. Among several alternative strategies, the use of nanoparticles synthesized using a natural product in the treatment of microbial infection has been considered a promising approach. The current study aimed to synthesize gold nanoparticles (AuNPs) using a natural product, fucoidan, and to test their efficacy against mono and duo combinations of fungal ( Candida albicans ) and bacterial ( Staphylococcus aureus / Streptococcus mutans ) biofilms. Several methods were used to characterize and study Fu-AuNPs, including UV-vis absorption spectroscopy, FTIR, FE-TEM, EDS, DLS, zeta potential, and XRD. The concentration-dependent inhibition of early-stage biofilms and the eradication of mature biofilms of single species of C. albicans , S. aureus , and S. mutans have been observed. Early biofilms of a dual-species combination of C. albicans and S. aureus / S. mutans were also suppressed at an increasing concentration of Fu-AuNPs. Furthermore, Fu-AuNPs significantly eradicated the established mature biofilm of mixed species. The treatment method proposed in this study, which involves the use of marine-bioinspired nanoparticles, is a promising and biocompatible agent for preventing the growth of polymicrobial biofilms of bacterial and fungal pathogens.
Keyphrases
- candida albicans
- biofilm formation
- gold nanoparticles
- staphylococcus aureus
- early stage
- squamous cell carcinoma
- pseudomonas aeruginosa
- escherichia coli
- multidrug resistant
- high resolution
- helicobacter pylori
- smoking cessation
- cystic fibrosis
- gram negative
- mass spectrometry
- reduced graphene oxide
- antimicrobial resistance